Mitiglinide (calcium hydrate) -d8
Mitiglinide (calcium hydrate) -d8 is the deuterium labeled Mitiglinide (calcium hydrate). Mitiglinide calcium hydrate (KAD-1229), an insulinotropic agent, is an ATP-sensitive K+ (KATP) channel antagonist. Mitiglinide calcium hydrate is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell KATP channel). Mitiglinide Calcium hydrate can be used for the research of type 2 diabetes[1][2].
Product Specifications
UNSPSC
12352005
Target
Isotope-Labeled Compounds; Potassium Channel
Related Pathways
Membrane Transporter/Ion Channel; Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Smiles
[H][C@]12[C@@]([H])(CCCC2)CN(C1)C(C[C@@](C(O)=O)(C([2H])(C3=C(C([2H])=C(C([2H])=C3[2H])[2H])[2H])[2H])[2H])=O.O.[0.5Ca]
Molecular Formula
C19H19D8Ca0.5NO4
Molecular Weight
361.51
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MUC18 / Mucin 18 / CD146 (OJ79c), CF405S conjugate, 0.1mg/mL
TGF-beta (1D11.16.8), CF770 conjugate, 0.1mg/mL
ACTH (Adrenocorticotrophic Hormone) (AH26), CF640R conjugate, 0.1mg/mL
